Article citationsMore>>

J. Corey-Bloom, R. Anand, J. Veach, “A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartarate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease,” Int. J. Geriatr. Psychopharmacol. Vol. 1, 1998, 55-65.

has been cited by the following article:

• TITLE: A Simple and Highly Efficient Enantioselective Synthesis of (S)-Rivastigmine

  AUTHORS: Veera R. Arava, Laxminarasimhulu Gorentla, Pramod K. Dubey

  KEYWORDS: Cholinergic Agent, Enantioselective, Highly Efficient, (S)-(-)-2-Methyl-2-Propane Sulfina-mide, (S)-Rivastigmine

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.1 No.2, June 30, 2011

  ABSTRACT: A highly efficient and convenient procedure for the enantioselective synthesis of (S)-Rivastigmine, a cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson’s disease, is accomplished by the treatment of versatile, readily accessible (S)-(-)-2-methyl-2-propanesulfinamide with 3-hydroxyacetophenone. This protocol provides high yield and excellent enantiomeric excess in short step synthesis.